Close Menu

NEW YORK — Co-Diagnostics said on Monday that its Logix Smart Coronavirus COVID-19 Test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration.

According to Salt Lake City, Utah-based Co-Diagnostics, the PCR-based, single-well test uses the company's CoPrimer technology to detect the RdRp gene of the SARS-CoV-2 virus. It received CE-IVD marking in February.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.